9 Meters Biopharma Inc. (NMTR) is primed for evolution with the beta value of -3.76 – Invest Chronicle

9 Meters Biopharma Inc. (NMTR) is primed for evolution with the beta value of -3.76

For the readers interested in the stock health of 9 Meters Biopharma Inc. (NMTR). It is currently valued at $1.93. When the transactions were called off in the previous session, Stock hit the highs of $2.09, after setting-off with the price of $1.7475. Company’s stock value dipped to $1.71 during the trading on the day. When the trading was stopped its value was $1.73.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on February 3, 2021, 9 Meters Biopharma, Inc. highlighted at upcoming Truist Securities’ CEO Strategic Vision Conference Call Series. 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, today announced its Executive Management team will participate in the “CEO Strategic Vision” Conference Call Series hosted by hosted by Srikripa Devarakonda, PhD and Robyn Karnauskas, PhD of Truist Securities on Wednesday, February 10, 2021. Please see additional details below: You can read further details here

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


9 Meters Biopharma Inc. had a pretty favorable run when it comes to the market performance.

9 Meters Biopharma Inc. (NMTR) full year performance was 155.49%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, 9 Meters Biopharma Inc. shares are logging 2.12% during the 52-week period from high price, and 421.48% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.37 and $1.89.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 21331981 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the 9 Meters Biopharma Inc. (NMTR) recorded performance in the market was 124.68%, having the revenues showcasing 166.94% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 397.72M, as it employees total of 8 workers.

Analysts verdict on 9 Meters Biopharma Inc. (NMTR)

During the last month, 4 analysts gave the 9 Meters Biopharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.9634, with a change in the price was noted +1.2200. In a similar fashion, 9 Meters Biopharma Inc. posted a movement of +171.83% for the period of last 100 days, recording 7,199,341 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NMTR is recording 0.36 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

9 Meters Biopharma Inc. (NMTR): Technical Analysis

Raw Stochastic average of 9 Meters Biopharma Inc. in the period of last 50 days is set at 88.65%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 84.31%. In the last 20 days, the company’s Stochastic %K was 83.80% and its Stochastic %D was recorded 86.13%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Let’s take a glance in the erstwhile performances of 9 Meters Biopharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 124.68%. Additionally, trading for the stock in the period of the last six months notably improved by 272.59%, alongside a boost of 155.49% for the period of the last 12 months. The shares increased approximately by 32.19% in the 7-day charts and went down by 37.86% in the period of the last 30 days. Common stock shares were driven by 166.94% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.